DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 3352--------------------------------------------------
       NARCOMS study results comparing disability worsening in patients
        on Tecfidera, Gilenya
       By: agate Date: July 19, 2021, 1:27 am
       ---------------------------------------------------------
       From Therapeutic Advances in Neurological Disorders (June 30,
       2021)--"A propensity-matched comparison of long-term disability
       worsening in patients with multiple sclerosis treated with
       dimethyl fumarate or fingolimod":
  HTML https://journals.sagepub.com/doi/full/10.1177/17562864211021177
       *****************************************************